APA (7th ed.) Citation

Chillotti, L., Colrat, F., Diez-Andreu, P., Brouquet, A., Gaudin, A., Bugnard, F., . . . Bellera, C. (2023). MSR137 Consideration of Competing Risks in Early Setting in Oncology and Impact on the Survival Estimates: To Explicitly Model Them? An Example of a French Real-World Cohort in Urothelial Carcinoma. Value in health, 26(12), S419. https://doi.org/10.1016/j.jval.2023.09.2195

Chicago Style (17th ed.) Citation

Chillotti, L., F. Colrat, P. Diez-Andreu, A. Brouquet, A.F Gaudin, F. Bugnard, S. Bénard, S. Branchoux, and C. Bellera. "MSR137 Consideration of Competing Risks in Early Setting in Oncology and Impact on the Survival Estimates: To Explicitly Model Them? An Example of a French Real-World Cohort in Urothelial Carcinoma." Value in Health 26, no. 12 (2023): S419. https://doi.org/10.1016/j.jval.2023.09.2195.

MLA (9th ed.) Citation

Chillotti, L., et al. "MSR137 Consideration of Competing Risks in Early Setting in Oncology and Impact on the Survival Estimates: To Explicitly Model Them? An Example of a French Real-World Cohort in Urothelial Carcinoma." Value in Health, vol. 26, no. 12, 2023, p. S419, https://doi.org/10.1016/j.jval.2023.09.2195.